Acute intermittent porphyria in women: Clinical expression, use and experience of exogenous sex hormones. A population-based study in northern Sweden

Journal of Internal Medicine

Volumn 254, Issue 2, 2003, Pages 176-183

  Andersson, C ^a   Innala, E ^a   Backstrom T ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute intermittent porphyria; Miscarriage; Sex hormone; Woman

Indexed keywords

ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTRIOL; ESTROGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; SEX HORMONE;

ACUTE INTERMITTENT PORPHYRIA; ADULT; AGED; ARTICLE; CHRONICITY; DISEASE SEVERITY; DNA DETERMINATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; POPULATION RESEARCH; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SPONTANEOUS ABORTION; SWEDEN; SYMPTOMATOLOGY; VAGINAL DRYNESS;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CONTRACEPTIVE AGENTS; CONTRACEPTIVES, ORAL; DRUG COMBINATIONS; ESTRADIOL; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; MIDDLE AGED; PORPHYRIA, ACUTE INTERMITTENT; PREGNANCY; PROGESTERONE; RETROSPECTIVE STUDIES; SWEDEN; VAGINA;

EID: 0042343896     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2003.01172.x     Document Type: Article

References (23)

1. Andersson C, Floderus Y, Wikberg A, Lithner F. The W198X and R173W mutations in the porphobilinogen deaminase gene in acute intermittent porphyria have higher clinical penetrance than R167W. A population-based study. Scand J Clin Lab Invest 2000; 60: 643-8.
2. Andersson C, Lithner F. Hypertension and renal disease in patients with acute intermittent porphyria. J Intern Med 1994; 236: 169-75.
3. Anderson KE. LHRH analogues for hormonal manipulation in acute intermittent porphyria. Semin Hematol 1989; 26: 10-5.
4. Tschudy DP, Valsamis M, Magnussen CR. Acute intermittent porphyria: clinical and selected research aspects. Ann Intern Med 1975; 83: 851-64.
5. Granick S. The induction in vitro of δ-aminolevulinic acid synthetase in chemical porphyria: a response to certain drugs. sex hormones and foreign chemicals. J Biol Chem 1966: 241: 1359-75.
6. Anderson K, Sassa S. Bishop D, Desnick R. Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. In: Scriver CR, Beaudet AL, Sly WS. Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 8th edn. New York: McGraw-Hill. 2001; 2991-3062.
7. Kauppinen R, Mustajoki P. Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases. Medicine 1992; 71: 1-13.
8. Anderson KE, Spitz IM, Bardin CW, Kappas A. A gonadotropin releasing hormone analogue prevents cyclical attacks of porphyria. Arch Intern Med 1990; 150: 1469-74.
9. Anderson KE, Spitz IM, Sassa S, Bardin CW, Kappas A. Prevention of cyclical attacks of acute intermittent porphyria with a long-acting agonist of luteinizing hormone-releasing hormone. N Engl J Med 1984; 311: 643-5.
10. Herrick AL. McColl KE, Wallace AM. Moore MR, Goldberg A. LHRH analogue treatment for the prevention of premenstrual attacks of acute porphyria. Q J Med 1990; 75: 355-63.
11. Welland FH, Hellman ES, Gaddis EM, Collins A, Hunter GW, Tschudy DP. Factors affecting the excretion of porphyrin precursors by patients with acute intermittent porphyria. 1. The effect of diet. Metabolism 1964; 13: 232.
12. Wetterberg L. International survey of safe and hazardous drugs in acute intermittent porphyria. Läkartidningen 1976; 73: 4090-2.
13. Zimmerman T. McMillin J, Watson C. Onset of manifestations of hepatic porphyria in relation to the influence of female sex hormones. Arch Intern Med 1966; 118: 229-40.
14. Gross U, Honcamp M. Daume E. Frank M, Dusterberg B, Doss MO. Hormonal oral contraceptives. urinary porphyrin excretion and porphyrias. Horm Metab Res 1995; 27: 379-83.
15. Perloth MG, Marver HS, Tschudy DP. Oral contraceptive agents and the management of acute intermittent porphyria. JAMA 1965: 194: 1037-42.
16. Schley G, Anlauf M, Bock KD. Orale Kontrazeptiva zur Prophylaxe akuter Schübe der intermittierenden Porphyrie [Oral contraceptives in prophylaxis of acute exacerbations of intermittent porphyria]. Dtsch Med Wschr 1976; 101: 1901-7.
17. Andersson C. Thunell S, Floderus Y et al. Diagnosis of acute intermittent porphyria in northern Sweden: an evaluation of mutation analysis and biochemical methods. J Intern Med 1995; 237: 301-8.
18. De Siervi A, Rossetti M, Parera V, Mendez M. Varela L, Batlle A. Acute intermittent porphyria: Biochemical and clinical analysis in the Argentinean population. Clinica Chimica Acta 1999; 288: 63-71.
19. Lip GY, McColl KE, Moore MR. The acute porphyrias. Br J Clin Pract 1993; 47: 38-43.
20. Wetterberg L, Olsson MB, Alm-Agvald I. Estrogen treatment caused acute attacks of porphyria. Läkartidningen 1995; 92: 2197-8.
21. Brodie MJ, Moore MR, Thompson GG, Goldberg A, Low RA, Pregnancy and the acute porphyrias. Br J Obstet Gynaecol 1977: 84: 726-31.
22. Lyberatos C, Chalevalakis G, Platis A, Gardikas C. Urinary porphyrins and their precursors in human pregnancy and after delivery. J Obstet Gynaecol Br Commonw 1972; 79: 921.
23. Wulff M, Högberg U, Stenlund H. Occupational and environmental risks of spontaneous abortions around smelter. Am J Ind Med 2002; 41: 131-8.